Monoclonal Mouse anti‑Human CRLF2 / TSLPR Antibody (clone 8H8, IHC, WB) LS‑C153299
Monoclonal Mouse anti‑Human CRLF2 / TSLPR Antibody (clone 8H8, IHC, WB) LS‑C153299
Antibody:
CRLF2 / TSLPR Mouse anti-Human Monoclonal (8H8) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
CRLF2 / TSLPR Mouse anti-Human Monoclonal (8H8) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
TSLPR antibody LS-C153299 is an unconjugated mouse monoclonal antibody to human TSLPR (CRLF2). Validated for ELISA, IHC and WB.
Target
Human CRLF2 / TSLPR
Synonyms
CRLF2 | IL-XR | ILXR | p2RY8/CRLF2 fusion | TSLP receptor | TSLPR | CRL2 | CRLF2Y | Cytokine receptor-like 2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1,k
Monoclonal
Conjugations
Unconjugated
Purification
Protein A purified
Immunogen
Recombinant human TSLP R /Fc chimera.
Specificity
Reacts with human 42 kD TSLP receptor.
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Reconstitution
100 µl Distilled water
Storage
Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at 4°C. For extended periods store in aliquots at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
Western blot, Flow Cytometry
Species:
Mouse
Applications:
Flow Cytometry
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Mouse
Applications:
Immunofluorescence, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/26/2024